NCT04561362 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT04561362
Title	Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies
Recruitment	Active, not recruiting
Gender	both
Phase	Phase Ib/II
Variant Requirements	Yes
Sponsors	Bicycle Tx Limited
Indications	pancreatic cancer esophageal cancer lung non-small cell carcinoma triple-receptor negative breast cancer head and neck cancer peritoneum cancer transitional cell carcinoma ovarian cancer Advanced Solid Tumor breast cancer fallopian tube cancer stomach cancer
Therapies	BT8009 BT8009 + Pembrolizumab
Age Groups:	adult \| senior
Covered Countries	USA \| ITA \| GBR \| FRA \| ESP \| CAN

NCT04561362
Clinical Trial Detail